New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2013
09:13 EDTONCYOncolytics Biotech reports FY12 EPS (C$0.48), consensus (43c)
Reports FY12 Research and development expensed C$31.4M.
News For ONCY From The Last 14 Days
Check below for free stories on ONCY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
07:38 EDTONCYOncolytics Biotech price target lowered to $3 from $5 at RBC Capital
Subscribe for More Information
September 17, 2014
10:00 EDTONCYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:10 EDTONCYOncolytics Biotech downgraded to Hold from Buy at Stifel
Stifel downgraded Oncolytics Biotech to Hold citing disappointing topline results from its Phase II pancreatic cancer study.
September 16, 2014
17:09 EDTONCYOncolytics Biotech announces patient data from phase 2 study with REOLYSIN
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use